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Abstract—The measurement of physical activity, especially
walking activity, is important for many outcome studies. In
many investigations, the Physical Activity scale of the short-
form-36 (SF-36) health assessment questionnaire is used in lieu
of an actual physical measurement of walking. This study deter-
mined the relationship between the SF-36 questionnaire and the
Step Activity Monitor (SAM), a real-world performance-based
tool that counts the actual number of steps taken during daily
activities. We studied the physical activity of 57 men with dia-
betes using step count monitoring and the SF-36 questionnaire.
The subjects averaged 3,293 steps/day, but had a very wide
range (111–11,654) and a large standard deviation (SD =
2,037). The correlations between total daily steps and the SF-36
Physical Component Summary score, and the Physical Func-
tion, Bodily Pain, and Vitality scales of the SF-36 were only fair
(Pearson’s r = 0.376, 0.488, 0.332, 0.380, respectively). The
corresponding coefficients of determination range from only
7.7% to 23.8%. Physical activity is a complex concept not com-
pletely represented by either the SF-36 or the step counts. The
correlation between actual walking activity and the SF-36 is not
as strong as many researchers believe. Caution should be exer-
cised with the use of the SF-36 to specifically measure walking
activity.
Key words: diabetes mellitus, diabetic neuropathies, health
status indicators, locomotion, outcome assessment, walking.
INTRODUCTION
Multidimensional measures for documenting patient
outcomes are increasingly important in today’s health-
care environment. Practitioners are being asked to dem-
onstrate that what they do actually makes a difference in
their patients’ lives. At the same time, researchers are
being asked to employ a broader, more comprehensive
array of measures to study health phenomena. This rela-
tively new emphasis on multidimensional outcomes is
related to the perceived need to reduce healthcare costs
and unwarranted variations in care, as well as develop
measures appropriate for monitoring the status of an aging
Abbreviations: MCS = Mental Component Summary, MOS =
Medical Outcomes Study, PCS = Physical Component Sum-
mary, PPMC = Pearson Product Moment Correlation, PPT =
Physical Performance Test, SAM = Step Activity Monitor, SD =
standard deviation, SF-36 = short-form 36, SIP = Sickness
Impact Profile, VA = Department of Veterans Affairs.
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betes [1–4]. Despite the emergence of the outcomes
movement as a major force for change within the con-
temporary healthcare system, determining which out-
comes are important and how to measure those outcomes
remain exceedingly complex and difficult tasks [5–8].
Three outcomes categories of importance to many
patients are health-related quality of life, general physical
function, and ambulatory activity. The two basic types of
tools that have been developed to measure physical
activity and walking include self-report measures and
performance-based measures. Examples of these differ-
ent types of tools follow, with an emphasis on how each
type independently measures health-related quality of
life, physical function, and ambulatory activity.
Self-Report Measures
Self-report measures are designed based on the belief
that patient perception is an important part of measuring
overall health status and response to treatment. Perhaps
the most widely used self-report measure of health-
related quality of life is the short-form 36 (SF-36) ques-
tionnaire developed within the Medical Outcomes Study
(MOS) [9]. The SF-36 relies upon 36 different questions,
the answers to which are used to generate a score in eight
different scales (Physical Functioning, Role Limitation
due to Physical Problems, Bodily Pain, General Health
Perceptions, Mental Health, Vitality, Role Limitation due
to Emotional Problems, and Social Functioning) and two
summary scores (Physical Component Summary [PCS]
and Mental Component Summary [MCS]). Average
expected norms stratified by age, gender, and diagnosis
are available for specific subgroups (for example, dia-
betic men) from many countries. Although not specifi-
cally measures of ambulatory ability, many items within
the SF-36 relate to gait activities and to social roles in the
context of ambulation.
Unfortunately, the SF-36 is not precise enough to
determine small differences in activity level. For example,
the Role Limitation/Physical score is measured on a scale
of 0 to 100 in 25-point increments, and the Physical Func-
tioning score is measured on a scale of 0 to 100 in 5-point
increments, both of which are far too coarse to provide
useful statistical data for measuring subtle changes in
activity. An additional limitation of the SF-36 and other
self-report measures is that large proportions of some
groups may score overwhelmingly at the top or bottom of
the scale. When large proportions of the population of
interest score at the ceiling or floor of the scale, this
makes the tool unresponsive to improvements in condi-
tions for those at the ceiling or to declines in function for
those at the floor.
Performance-Based Measures
Performance-based measures reflect the belief that
important outcomes exist apart from patient perceptions
and are best observed and measured by practitioners and
researchers. Performance-based measures include tools
that assign scores according to laboratory-based or simu-
lated activities, as well as those that document actual per-
formance during real-world daily activities.
Laboratory-Based and Simulated Measures
Laboratory-based performance measures, including
the measurement of joint kinematics, electrical activity of
muscles, and ground reaction forces, have been a founda-
tion of the study of ambulatory activity [10]. For simulated
performance measures of gait, patients are asked to exe-
cute a series of activities designed to mimic the demands
of home and community ambulation. For example, the
Physical Performance Test (PPT) consists of single repeti-
tions of tasks such as putting a book on a high shelf, walk-
ing 50 feet, and picking up a penny from the floor [11].
Because these measures necessarily document activity
only within a brief observation period and within a very
controlled setting, they do not address the broader issues
of what patients actually do in the real-world setting.
Real-World Measures
Real-world performance measures of gait activity,
while not widely used, have been available for more than
20 years. In 1979, Holden et al. reported the use of a foot
switch and storage device to count steps as an objective
measure of rehabilitation after lower-limb amputation
[12]. During this same period, Day et al. also developed a
foot-switch step counter that, following a 10-day data
collection period, could be used to extrapolate the yearly
step count of individuals after amputation [13,14]. A
more contemporary step counting device is the Step
Activity Monitor (SAM), a pager-sized device that
attaches to a patient’s ankle [15]. The current version of
the SAM can record the actual number of steps taken
each minute for a period of at least 30 days. This real-
world measure can contribute to what we know about
how much people actually walk during a day and how
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Relationships Among Types of Measures
A number of authors have studied the relationship
between self-report and laboratory performance-based or
simulated performance-based measures. Rueben and
colleagues compared several self-report measures (the
SF-36, among others) with the simulated PPT [11]. They
found that relationships between the different types of
self-report measures were generally stronger (correla-
tions from 0.51 to 0.76) than the relationships between
any of the self-report measures and the performance-
based measures (correlations of 0.26 to 0.55). In a later
study, Sherman and Reuben found similar results, docu-
menting high correlations between simulated perfor-
mance-based measures (PPT and the National Institute on
Aging Battery) and only moderate correlations between
the simulated performance-based measures and self-
report measures (two activities of daily living tools and
the SF-36) [16].
Cress and colleagues documented correlations ranging
from –0.36 to –0.63 between the self-reported Sickness
Impact Profile (SIP)—specifically, the physical dimension
summary score and its subscales—and the laboratory-
based performance measure of gait of older adults [17]. It
is not surprising the self-reported physical function mea-
sures, which presumably capture the patient’s perception
about function across time in real-world settings, are not
highly correlated with laboratory-based or simulated per-
formance tests, which capture performance at limited
intervals under controlled conditions.
Very little research exists documenting the relationship
between self-report and real-world performance measures
of physical activity. Day’s 20-year-old study relied upon a
questionnaire designed by the author and uncovered a sig-
nificant correlation between step count per annum and the
activity score of individuals with lower-limb amputation
[14]. Our study explored the relationship between self-
reported and real-world performance measures of physical
activity and walking.
METHODS
Participants
Male veterans with diabetes identified from our
facility were enrolled in this study. Eligibility criteria
included that participants be male, be older than 18 years
of age, be ambulatory, test positive for diabetes, test posi-
tive for peripheral neuropathy, have lower-limb amputa-
tion or both, and have the cognitive ability to fill out
questionnaires. Diabetes was considered present if diag-
nosed by a physician or if the patient received oral
hypoglycemic medication or insulin. A total of 57 men
completed the study (average age 68 years, range 41 to
85 years). All amputee participants had been using pros-
theses, if required, for at least 1 year prior to their partici-
pation in this study.
Instrumentation 
We performed step-count gait assessment using the
SAM to record the number of right footsteps the subjects
took every 2.5 minutes for 14 continuous days. We nor-
malized the data to 1-minute intervals for analysis. This
instrument is a small, self-contained, waterproof device
that attaches to the patient’s right ankle and continuously
records step counts over successive, discrete time inter-
vals. With steps measured in small units of time, the data
gave the researcher insight into the speed of walking and
into the patients’ varying levels and patterns of activity in
a real-world setting. This tool has 99 percent accuracy in
counting steps on level surfaces and 97 percent on stairs
and hills [15].
We used the SF-36 questionnaire to determine health-
related quality of life. Participants completed the standard
English language version, which instructs participants to
answer each question in the context of the last 4 weeks.
Procedures
Participation involved three separate visits. At the
first visit, eligibility for the study was determined and
informed consent for participation was obtained. The sec-
ond visit entailed fitting and calibrating a SAM to each
participant. Participants were instructed to wear the
device continually for a 2-week period except when
sleeping and bathing. At the third visit, at the end of the
2-week period following the step-count data collection,
participants returned their SAM and completed the SF-36
questionnaire.
Data Analysis
We measured the step-count data as the discrete num-
ber of steps taken by the participant in each small block
of time. For statistical analysis, the step data was calcu-
lated into four different measures of walking activity for
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age number of steps taken per day was calculated as an
overall summary score. The device records only the steps
of the right leg; therefore, a rate of 60 steps/min with this
device corresponds to a walking cadence (individual right
and left steps) of 120 steps/min.
Second, we calculated the amount of time spent at
various rates of walking to determine the average number
of minutes spent per day being inactive (no steps/min), in
very low ambulatory activity (1 to 2 steps/min), in low
activity (3 to 10 steps/min), in moderate activity (11 to 30
steps/min), in high activity (31 to 60 steps/min), and in
very high activity (>61 steps/min). Third, we measured
the percentages of time spent at the various activity lev-
els. Fourth, we added up the percentage of time spent at
moderate, high, and very high levels of activity to pro-
vide a value showing the proportion of time spent at or
above moderate level activities.
The SF-36 questionnaires were scored according to
standard scoring algorithms. Scores for each of the eight
general scales and for the two summary scores were
calculated [18].
We gauged descriptive statistics for the variables,
including the percentage of participants who were at the
floor or ceiling values for variables in which a floor or ceil-
ing existed. For the eight different SF-36 scales, the floor
was a score of 0 and the ceiling a score of 100. For the two
summary scores, each of which was normalized with the
general U.S. population to an average score of 50 with a
standard deviation (SD) of 10, floor and ceiling effects are
essentially eliminated.
For the step-count data, floor values were noted
when the patient did not take any steps at the given activ-
ity level. Even though a theoretical ceiling exists for
these data, in practice, there is no given value at which
the variables typically “top out,” so only floor percent-
ages were reported. We used 1-group t-tests to establish
whether or not the SF-36 summary scores for this sample
were significantly different from various population
norms. Alpha was set at 0.05 for these comparisons.
Relationships among the SF-36 variables and the
step-count variables were verified with the use of Pear-
son Product Moment Correlations (PPMCs). Because the
pattern of correlations was the same no matter how the
step-count data were presented (percentage of time at a
given level, minutes at a given activity level, or percent-
age of active time at a given level), only the correlations
between the SF-36 data and the percentage of time at a
given level are presented here. Correlations that were sig-
nificant at p = 0.01 and p = 0.05 are noted in the results.
Because of the possibility of associations between sub-
ject age, the SF-36 score, and the step-count variables,
we calculated PPMC between age and these variables.
RESULTS
Table 1 shows the descriptive statistics for the step-
count data. The average number of steps per day for the
Table 1.
Descriptive statistics for step-count variables.
Variable Mean SD Minimum Maximum % at Floor
Total Steps 3292.8 2036.6 111.0 11654.0 0.0
Minutes with No Steps 1094.0 132.6 765.4 1391.3 0.0
Minutes at Very Low Step Rate 86.3 43.9 31.9 221.0 0.0
Minutes at Low Step Rate 139.8 50.6 6.0 249.3 0.0
Minutes at Moderate Step Rate 103.4 59.5 4.6 297.7 0.0
Minutes at High Step Rate 16.5 23.8 0.0 117.7 5.3
Minutes at Very High Step Rate 0.005 0.23 0.0 2.0 93.0
Percentage of Time with No Step Rate 76.0 9.2 53.2 96.6 0.0
Percentage of Time at Very Low Step Rate 6.0 3.1 2.2 15.4 0.0
Percentage of Time at Low Step Rate 9.7 3.5 0.4 17.3 0.0
Percentage of Time at Moderate Step Rate 7.2 4.1 0.3 20.7 0.0
Percentage of Time at High Step Rate 1.1 1.7 0.0 8.17 5.3
Percentage of Time at Very High Step Rate 0.004 0.02 0.0 0.1 93.0
Percentage of Time at Moderate, High, or Very High Step Rate 8.3 5.3 0.3 28.9 0.0
SD = standard deviation 
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and SD (SD = 2,037) reveal tremendous variation in
ambulatory activity between these subjects. The percent-
age of inactive time for the subjects averaged 76.0 percent
(SD = 9.2), the percentage of time spent walking at very
low levels of ambulation (1 to 2 steps/min) = 6.0 percent
(SD = 3.1), low levels of activity (3 to 10 steps/min) =
9.7 percent (SD = 3.5), moderate activity (11 to 30 steps/
min) = 7.2 percent (SD = 4.1), high activity (31 to 60 steps/
min) = 1.1 percent (SD = 1.7), and very high activity
(>61 steps/min) = 0.004 percent (SD = 0.02). The percent-
age of time spent when adding moderate, high, and very
high levels of activity was 8.3 percent (SD = 5.3). It should
be noted that 3 out of 57 participants recorded no activity
at high step-count levels, and 51 out of 57 participants
recorded no activity at very high step-count levels.
Table 2 shows the descriptive statistics for the SF-36
data. Nearly half the participants scored at the floor in
both the Role Limitation/Physical and Role Limitation/
Emotional variables. One-fifth of the participants scored
at the ceiling of the Role Limitation/Physical, and one-
third of participants scored at the ceiling of the Social
Function and Role Limitation/Emotional variables. The
PCS sample mean of 34.1 for our study population was
significantly different than the means for men aged 65
and older from the U.S. population (PCS mean of 41.95,
t = –6.196, p = 0.000), for individuals with diabetes in the
general U.S. population (PCS mean of 39.30, t = –4.114,
p = 0.000), and for individuals with diabetes in the MOS
study (PCS mean of 41.52, t = –5.858, p = 0.000) [18].
The MCS sample mean of 48.3 was significantly different
than the published means for men aged 65 and older from
the U.S. population (MCS mean of 52.51, t = – 2.925, p =
0.005) and for individuals with diabetes in Ware’s MOS
(MCS mean 51.90, t = –2.502, p = 0.015), but not for
individuals with diabetes in the general U.S. population
(MCS mean of 47.90, t = 0.272, p = 0.786) [18].
Table 3 shows the PPMCs among the SF-36 variables
and selected step-count variables. Because the step-count
data for the high and very high levels of activity were not
normally distributed within our sample, the assumptions
required for generating valid correlations with these vari-
ables were not met. Of the 60 PPMCs shown in Table 3,
the 11 that range from 0.488 to 0.356 are significant at
0.01 and an additional eight that range from 0.338 to 0.273
are significant at 0.05.
In general, the strongest relationships (those that are
significant at 0.01) are the correlations between the Phys-
ical Function scale, PCS score, and Vitality scale with the
total number of steps, the percentage of inactive time, the
percentage of time with moderate activity, and the per-
centage of time with moderate and higher levels of activ-
ity. The somewhat weaker relationships (those that are
significant at 0.05) are the Bodily Pain and Role Limita-
tion/Emotional scales when correlated with a variety of
step-count variables. The coefficients of determination
values (r2) calculated from the significant relationships
show that from 7.8 percent to 23.8 percent of the variabil-
ity in scores is shared among the SF-36 variables and the
various step-count variables. The Figure shows a scatter
plot of the total steps per day against the SF-36 Physical
Function score.
Finally, the subject’s age was not strongly associated
with the SF-36 scores or the step-count variables. In fact,
there were only two significant correlations between age
and these variables. Increasing age was associated with
Table 2.
Descriptive statistics for SF-36 variables.
Variable Mean SD Minimum Maximum % at Floor % at Ceiling
PCS Score 34.1 9.6 9.8 55.3 0.0 0.0
Physical Function 42.2 27.8 0.0 95.0 1.8 0.0
Role Limitation/Physical 32.9 39.3 0.0 100.0 45.6 19.3
Bodily Pain 58.0 23.9 0.0 100.0 1.8 7.0
General Health 47.6 22.9 0.0 92.0 1.8 0.0
MCS Score 48.3 10.9 20.5 67.6 0.0 0.0
Vitality 48.3 22.7 5.0 100.0 0.0 1.8
Mental Health 73.4 18.3 8.0 100.0 0.0 1.8
Social Function 69.7 26.3 0.0 100.0 1.8 29.8
Role Limitation/Emotional 42.1 45.2 0.0 100.0 47.4 33.3
PCS = Physical Component Summary MCS = Mental Component Summary SD = standard deviation
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Scatter plot of steps per day versus Physical Function component of the SF-36.
Table 3.
Pearson’s correlations between step-count measurements and SF-36 scales.
Variable PCS PhysicalFunction
Bodily
Pain
Role 
Physical
General
Health MCS Vitality
Mental
Health
Role 
Emotional
Social 
Function
Total Steps/Day 0.376* 0.488* 0.332† 0.082 0.134 0.101 0.380* 0.069 0.242 0.056
% of Inactive Time −0.324† −0.391* −0.319† −0.042 −0.211 −0.157 −0.427* −0.186 −0.154 −0.089
% Time Spent at Very Low 
Level of Activity
0.055 0.028 0.222 −0.083 0.131 0.142 0.244 0.216 −0.020 0.056
% Time Spent at Low Level of 
Activity
0.246 0.279† 0.203 0.021 0.196 0.094 0.338† 0.192 0.014 0.053
% Time Spent at Moderate 
Level of Activity
0.356* 0.461* 0.240 0.138 0.206 0.170 0.388* 0.106 0.284† 0.129
% Time Spent at Moderate or 
Higher Levels of Activity
0.371* 0.483** 0.294† 0.107 0.163 0.129 0.381* 0.073 0.273† 0.087
*Correlation is significant at the 0.01 level (2-tailed).
†Correlation is significant at the 0.05 level (2-tailed).
PCS = Physical Component Summary
MCS = Mental Component Summary 
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p = 0.016). Increasing age was associated with higher
self-reported pain (represented by lower scores on the
Bodily Pain scale, r = –0.292, p = 0.038).
The coefficients of determination show that from
8.5 percent to 11.4 percent of the variability in scores is
shared between age and the Physical Function and Bodily
Pain scales.
DISCUSSION
Measurement Characteristics
Our first goal was to examine the measurement char-
acteristics of both instruments used in this study. We
found that the SAM objectively measures activity in
ways that are attractive to practitioners and researchers.
First, the data can take an infinite number of values, mak-
ing it potentially very sensitive to small changes in status.
Second, ceiling effects essentially have no problems and
few problems with floor effects, meaning that either
improvements or declines in ambulatory function should
be measurable for most individuals. In our sample,
although we saw floor effects at the higher levels of
activity, the other step-count variables, such as total num-
ber of steps and percentage of time spent in moderate
level gait activity, demonstrated a range of scores that
neither “topped out” nor “bottomed out” the scale.
For this group of patients, we found the SF-36 ques-
tionnaire to be a less effective means of measuring activ-
ity, a phenomenon consistent with problems reported in
the previous literature. Chief among these problems is
that substantial proportions of our participants were at
either the floor or ceiling value for the various SF-36
scales [19]. This decreased the variability for each scale,
and thereby reduced the possibility for high correlations
with any other variables. This problem is additionally
confounded by the fact that if used to track change over
time, these particular SF-36 scales are not sensitive to
improvements or declines. Our data also confirm the ben-
efits of using the summary scores (PCS and MCS) with
SF-36 data, since floor and ceiling effects for these sum-
mated, normalized summary scales were eliminated.
One benefit of the SF-36 is the large number of
groups to which study data can be compared. The SF-36
data for the participants in this study showed lower levels
of health-related quality of life than several relevant com-
parison groups, including men over the age of 65 years
from the general U.S. population (significant difference
for the PCS and MCS), individuals with diabetes from
the general U.S. population (significant difference on the
PCS), and individuals with diabetes from the MOS (sig-
nificant difference on the PCS and MCS). This finding
does not surprise us, because all the participants had
experienced at least one serious complication related to
diabetes, including peripheral neuropathy, lower-limb
amputation, or both. These low SF-36 scores may also be
related to the participants’ status as veterans. Kazis and
associates found that veterans receiving care with the
Department of Veterans Affairs (VA) Health Care System
had significantly lower SF-36 scores than age-matched
non-VA populations [20].
Relationships Between Measures
The correlations we identified between SF-36 vari-
ables and step-count variables ranged from 0.273 to 0.488.
PPMCs lie within the range of –1 to +1, with the midpoint
of zero indicating no linear association between the two
variables. While a real correlation exists, it is not as strong
as many researchers have assumed. Evaluation of the scat-
ter plots can be very insightful to reveal the tremendous
variation that exists within this data set (Figure).
Another method useful for putting PPMCs into per-
spective is to calculate the percentage of the variability of
the data that are “explained” by the association between
the two variables. For the step-count data and the SF-36
data, the corresponding coefficients of determination
range from only 7.7 percent to 23.8 percent. Given the
wide range of physical skills that are used in items within
the SF-36, it is important to note that gait performance
(measured here as actual step counts) may account for
only one-quarter of the variability in perceptions of phys-
ical function as a self-reported measure. Interestingly, the
age of our participants was not correlated to most of the
SF-36 and step-count variables, with the exception of the
Physical Function and Bodily Pain scales. Perhaps the
fact that all subjects had the chronic disease of diabetes
might have blunted any expected association between
age and step counts.
Two important conclusions can be drawn from this
finding. First, ambulation status appears to be an outcome
that matters to patients. This conclusion should not be
surprising, because the patient’s difficulty with ambula-
tion is frequently cited as the reason for consulting health
care providers. Our data support this anecdotal evidence
and provide supports that ambulation status, as measured
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reported health-related quality of life. Notably, the corre-
lations we found between SF-36 scores and step counts
were lower than the correlations that other investigators
have documented between various self-reported and
laboratory-based physical activity measures [11,16–17]. 
The second important conclusion to be drawn from
our finding is that although related, ambulation status and
self-reported health-related quality of life capture differ-
ent components of the overall construct of health. For
example, the large variation in actual steps per day for a
given SF-36 Physical Function score reveal the SF-36’s
limitations in capturing daily ambulatory activity for an
individual subject (Figure). Examining the individuals at
the extremes of the SF-36 Physical Function category,
those with scores of 90 and 15, respectively, illustrates
this point. The four individuals with SF-36 scores of 90
in Physical Function had a wide range of average daily
step counts ranging from 1,261 to 11,654 steps per day.
The seven individuals with SF-36 scores of only 15 in
Physical Function had average daily step counts ranging
from 393 to 4,790 steps per day. This example illustrates
that there is a great deal of overlap in the exact number of
steps taken per day by individuals with very different
self-reported health status.
Although significant correlations were found
between the step-count variables and the SF-36 PCS
score and two of its scales (Physical Function and Bodily
Pain), the correlations were only fair. Also of interest was
that two scales of the MCS score (Vitality and Role Limi-
tation/Emotional) were also related to some of the step-
count variables. This study provides evidence of a limited
relationship of actual ambulatory activity to self-reported
measures related to energy, fatigue, and emotional roles.
SUMMARY AND CONCLUSIONS
Step-count data revealed great variation in ambula-
tory activity and few problems with floor or ceiling effects
for men with diabetes. SF-36 data revealed substantial
deviations from population norms for the PCS, minor
deviations for the MCS, and ceiling and floor effects on
several subscales for many participants. From 7.7 percent
to 23.8 percent of the variability in scores is shared among
the SF-36 and step-count variables. From these results, we
conclude that physical activity is a complex concept that
is not completely represented by either the SF-36 tool or
by step counts. Researchers should exercise caution when
using the SF-36 to specifically measure walking activity.
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